2005
DOI: 10.4103/0019-5359.15091
|View full text |Cite
|
Sign up to set email alerts
|

Antibacterial resistance: Current problems and possible solutions

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

0
77
0
2

Year Published

2008
2008
2022
2022

Publication Types

Select...
7
2

Relationship

0
9

Authors

Journals

citations
Cited by 97 publications
(79 citation statements)
references
References 2 publications
0
77
0
2
Order By: Relevance
“…Since facilities for microbiological studies at the first contact physician/surgeon are usually not available in district hospitals/smaller cities in India, indiscriminate antimicrobial therapy (i.e. without establishing the aetiology of the infection) eradicates susceptible Gram-positive cocci and, as a result, selects resistant Gram-positive cocci and Gram-negative bacilli, as well [23,24] .…”
Section: Discussionmentioning
confidence: 99%
“…Since facilities for microbiological studies at the first contact physician/surgeon are usually not available in district hospitals/smaller cities in India, indiscriminate antimicrobial therapy (i.e. without establishing the aetiology of the infection) eradicates susceptible Gram-positive cocci and, as a result, selects resistant Gram-positive cocci and Gram-negative bacilli, as well [23,24] .…”
Section: Discussionmentioning
confidence: 99%
“…Apenas metade dos isolados foram sensíveis à neomicina e à estreptomicina. O fraco desempenho desses fármacos pode ser creditado ao seu uso intensivo em medicina veterinária, muitas vezes de forma abusiva, indiscriminada e sem respaldo em testes de sensibilidade (Sharma et al, 2005), o que aumenta a pressão de seleção para linhagens bacterianas multirresistentes a antimicrobianos, inclusive de uso humano, como é o caso da ciprofloxacina (Andriole, 2005). Como consequência, há problemas de saúde pública relacionados ao surgimento de animais reservatórios de cepas multirresistentes para seres humanos contactantes.…”
Section: Resultsunclassified
“…22,26 The resistance exhibited by E.coli to aminoglycosides varies. In this study, 19% gentamicin resistance in non-ESBL producing and 1% resistant in ESBL producing E.coli was observed but 37.5% resistance to gentamicin was reported in another study.…”
Section: Discussionmentioning
confidence: 99%